Literature DB >> 16471557

Self-consistent-field analysis of the micellization of carboxy-modified poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers.

Y Lauw1, F A M Leermakers, M A Cohen Stuart.   

Abstract

The micellization properties of carboxy-modified Pluronics P85 (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) triblock copolymers) are investigated by means of a molecularly realistic self-consistent-field theory. We consider the, so-called, carboxylic acid end-standing P85 (CAE-85) case where the carboxylic group is located at the end of both PEO parts and the carboxylic acid center-standing P85 (CAC-85) case where each of the carboxylic group presents between the PEO and PPO blocks. The micellization of these copolymers depends on the pH, the added electrolyte concentration phis, and the temperature. It is shown that the aggregation number (Nagg) decreases, whereas the critical micellization concentration (CMC) increases with pH. For the case of increasing phis, the Nagg increases and the CMC decreases. The critical micellization temperature (CMT) and cloud point temperature (CPT) increase with pH at low phis and decrease at increasing phis. The changing from CAE-85 to CAC-85 leads to increasing CMC and CMT, but lower CPT.

Entities:  

Year:  2006        PMID: 16471557     DOI: 10.1021/jp053795a

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  2 in total

1.  Controlled block copolymer micelle formation for encapsulation of hydrophobic ingredients.

Authors:  Jérôme G J L Lebouille; Leo F W Vleugels; Aylvin A Dias; Frans A M Leermakers; Martien A Cohen Stuart; Remco Tuinier
Journal:  Eur Phys J E Soft Matter       Date:  2013-09-26       Impact factor: 1.890

2.  Dual responsive PMEEECL-PAE block copolymers: a computational self-assembly and doxorubicin uptake study.

Authors:  Amin Koochaki; Mohammad Reza Moghbeli; Sousa Javan Nikkhah; Alessandro Ianiro; Remco Tuinier
Journal:  RSC Adv       Date:  2020-01-20       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.